Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Expert Review of Clinical Pharmacology|November 18, 2023
Determinants of adherence to treatment in patients with ophthalmic conditionsPatricia Muñoz-Villegas, Humberto Martínez-Bautista, Oscar Olvera-Montaño
Clinical Ophthalmology (Auckland, N.Z.)|October 12, 2023
The Effect of Sodium Hyaluronate Eye Drops 2, 4 or 6 Times a Day on Signs and Symptoms of Dry Eye DiseasePatricia Del Carmen Muñoz-Villegas, Alejandra Sánchez-Ríos, Oscar Olvera-Montaño
Journal of Ophthalmology|April 20, 2023
Efficacy and Safety of an Ophthalmic DMPC-Based Nanoemulsion in Patients with Dry Eye Disease: A Phase I/II Randomized Clinical TrialLeopoldo M Baiza-Durán, Patricia Muñoz-Villegas, Alejandra Sánchez-Ríos, et al.
BMJ Open Ophthalmology|August 29, 2024
Prostaglandin analogues signal detection by data mining in the FDA Adverse Event Reporting System databaseHomero Contreras-Salinas, María Soledad Romero-López, Oscar Olvera-Montaño, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 25, 2026
Assessment of the Effectiveness, Tolerability, and Safety of the Preservative-Free Fixed Combination of Timolol, Dorzolamide, and Brimonidine Compared to Separate Therapies in Patients with Glaucoma, a Randomized Controlled TrialSandra Belalcazar, Andrea Tornero-Jimenez, Claudia Mejia-Morales, et al.
Ophthalmology and Therapy|August 6, 2023
Evaluation of the Relationship Between Diabetic Macular Edema and Renal Function in a Latino PopulationJosé M Torres-Arellano, Andrea Tornero-Jimenez, Alejandra Sánchez-Ríos, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 28, 2025
Maximum Tolerated Medical Therapy for Glaucoma: Fixed-Dose Combinations of Timolol, Dorzolamide, Brimonidine with Latanoprost Versus Timolol, Dorzolamide with LatanoprostOscar Olvera-Montaño, Claudia Mejia-Morales, Ricardo O Jauregui-Franco, et al.
Therapeutics and Clinical Risk Management|October 28, 2021
Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical TrialsPatricia Muñoz-Villegas, Andrea A Navarro-Sánchez, Alejandra Sánchez-Ríos, et al.
Therapeutic Advances in Drug Safety|April 28, 2025
Mydriasis mediated by local anesthetics: an unexpected adverse event or new therapeutic indication?Homero Contreras-Salinas, Janet Cristina Vázquez-Beltrán, María Soledad Romero-López, et al.
Journal of Ophthalmic Inflammation and Infection|March 22, 2017
Bioavailability of generic 0.05% difluprednate emulsion in the aqueous humor, cornea, and conjunctiva of New Zealand rabbits after a single dose compared with commercial difluprednateArieh Mercado-Sesma, Angélica Contreras-Rubio, Leopoldo Baiza-Durán, et al.
Pageof 3